Biovie (BIVI) Cash from Financing Activities (2013 - 2025)

Biovie has reported Cash from Financing Activities for 11 years, with the latest figure at $10.5 million in Q3 2025.

• Quarterly Cash from Financing Activities rose 4440.4% year-over-year to $10.5 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $10.5 million (up 2.27% YoY) and the FY2025 annual result came in at $12.7 million, down 28.52% from the prior year.
• Cash from Financing Activities declined to $10.5 million in Q3 2025 per BIVI's latest filing, from $13.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $33.1 million in Q3 2022 and troughed at -$2.5 million in Q2 2024.
• A 5-year average of $10.1 million and a median of $9.8 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities tumbled 297.09% in 2024, then surged 4440.4% in 2025.
• Over 5 years, Cash from Financing Activities stood at $14.6 million in 2021, then surged by 122.64% to $32.5 million in 2022, then sank by 84.87% to $4.9 million in 2023, then jumped by 163.45% to $13.0 million in 2024, then retreated by 19.35% to $10.5 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $10.5 million, $13.0 million, and -$240937.0 for Q3 2025, Q4 2024, and Q3 2024 respectively.